CHLOROTHIAZIDE W/ RESERPINE Drug Patent Profile
✉ Email this page to a colleague
When do Chlorothiazide W/ Reserpine patents expire, and when can generic versions of Chlorothiazide W/ Reserpine launch?
Chlorothiazide W/ Reserpine is a drug marketed by Watson Labs and is included in two NDAs.
The generic ingredient in CHLOROTHIAZIDE W/ RESERPINE is chlorothiazide; reserpine. There are forty-two drug master file entries for this compound. Additional details are available on the chlorothiazide; reserpine profile page.
Summary for CHLOROTHIAZIDE W/ RESERPINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 2 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | CHLOROTHIAZIDE W/ RESERPINE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for CHLOROTHIAZIDE W/ RESERPINE
US Patents and Regulatory Information for CHLOROTHIAZIDE W/ RESERPINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | CHLOROTHIAZIDE W/ RESERPINE | chlorothiazide; reserpine | TABLET;ORAL | 084853-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Watson Labs | CHLOROTHIAZIDE W/ RESERPINE | chlorothiazide; reserpine | TABLET;ORAL | 088151-001 | Jun 9, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
